Aspi-rub
NDC Package 69151-100-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Aspi-rub is adults and children over the age of 12 years, apply generously to painful areas with a gentle circular massage 3 to 4 times daily. Marketed by Aspirub Enterprises Llc, this product is identified by NDC 69151-100 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
69151-100-01
Package Description
59 g in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
69151010001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Aspi-rub Pain Reliever
Dosage Form
-
Usage Information
Adults and children over the age of 12 years, apply generously to painful areas with a gentle circular massage 3 to 4 times daily. Children under 12 years of age consult a doctor.

Regulatory & Marketing

Labeler Name
Aspirub Enterprises Llc
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
08-29-2014
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69151-100-01 identifies a specific commercial package of 59 g in 1 bottle, plastic of Aspi-rub Pain Reliever, labeled by Aspirub Enterprises Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aspirub Enterprises Llc on August 29, 2014. The current certification is valid through December 31, 2017.

How is this Aspirub Enterprises Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69151010001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69151-100-01
11-Digit CMS (5-4-2)
69151-0100-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.